For the past two years, we've convened industry leaders to dig deep into the health insurance sector's hottest market—Medicare Advantage—in a series of virtual forums.
Now, we're looking to take that conversation farther and bring together top minds in the payer space at the inaugural Fierce Health Payer Summit, taking place on Nov. 2 and 3 in Austin, Texas.
The Fierce Healthcare editorial team has led the way in crafting an agenda that crosses some of the most critical concerns facing health plans: health equity, digital evolution, value-based care, health policy and more.
REGISTER HERE FOR THE FIERCE HEALTH PAYER SUMMIT
Intrigued? Here's a closer look at what we have in store later this fall:
One-on-one with industry luminaries
Keynote sessions with Humana's J. Nwando Olayiwola, M.D., and SCAN Group's Karen Schulte will shine a spotlight on leaders on the front lines of transforming the way payers do business.
Olayiwola, Humana's first chief health equity officer, joined the company in 2021 and leads its strategy around addressing inequities endemic in the health system. She's an internationally known voice on health equity and public health as well as a practicing family physician.
Schulte leads SCAN's Medicare division and is overseeing its growth and performance in that market. She's held multiple leadership roles across the company and has also served in key positions at CareMore and Aspire Health, affiliates of Elevance Health.
Catch Olayiwola at 8:45 a.m. CT on Nov. 2 and Schulte at 8:45 a.m. CT on Nov. 3.
The shift toward greater value
Staff writer Anastassia Gliadkovskaya will helm a panel examining where we stand in the push toward value-based care. We've convened experts at both payers and providers to discuss how these two segments of the industry can come together in the drive for value.
During the panel, hear from Don Antonucci, CEO of Providence Health Plan; Misha Palecek, chief transformation officer at DaVita; and Will Johnson, vice president and general manager of +Oscar Modular Solutions.
Join us for the session at 11:45 a.m. CT on Nov. 2.
Policy updates that matter to your business
Staff writer Dave Muoio will sit down with Donald Rucker, M.D., chief strategy officer for 1upHealth and former national coordinator for health IT, and Kathy Hempstead, senior policy adviser for the Robert Wood Johnson Foundation, to discuss the key policy trends for payers to watch.
Expect to hear talk about interoperability, new payment models, Medicaid redetermination and more.
The session will kick off at 9:45 a.m. CT on Nov. 3.
The latest in digital transformation
Virtual care took off during the COVID-19 pandemic, and it's not going anywhere. Senior Editor Heather Landi will helm a panel digging into what insurers need to do to stay competitive as members continue to expect a digitally enabled, consumer-centric experience.
She'll be joined by Peter Long, executive vice president for strategy and health solutions at Blue Shield of California; Timothy Law, D.O., chief medical officer at Highmark; and Eric Weil, M.D., chief medical officer for MDLive by Evernorth.
Catch the panel at 9:15 a.m. CT on Nov. 2.
Medicare Advantage is still full-speed ahead
Payers still view Medicare Advantage as a key growth target, and the industry's biggest players have major ambitions in this space. However, recent policy changes are set to play a critical role in how this push shapes up over the next several years.
As your moderator, I'll chat with Dawn Maroney, CEO of Alignment Health Plan; Jamie Reynoso, CEO of Medicare Advantage at Clover Health; and Tracy Nolan, senior vice president of MarketPoint at Humana.
The session begins at 4:30 p.m. CT on Nov. 2.
If you'd like to join us for these sessions and even more critical conversation at the summit, register now!
If you're an executive at a payer or provider organization, apply for a complimentary executive pass. You must be a qualified executive at a health plan, plan administration or provider company to qualify and must register with your work address. Complimentary pass requests are subject to approval and may be denied.